Modulation of glucose-6-phosphatase translocase expression

Details for Australian Patent Application No. 2005244764 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Dobie, Kenneth W.; Bhanot, Sanjay

Agent Pizzeys

Pub. Number AU-B-2005244764

PCT Pub. Number WO2005/113016

Priority 60/564,641 21.04.04 US; 60/576,478 02.06.04 US; 11/111,288 20.04.05 US; 60/615,395 30.09.04 US

Filing date 21 April 2005

Wipo publication date 1 December 2005

Acceptance publication date 8 January 2009

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/113016 Priority application(s): WO2005/113016

8 January 2009 Application Accepted

  Published as AU-B-2005244764

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244768-Cancer treatment using viruses and camptothecins

2005244754-Disposable, one-piece, self-adhesive, all-surface, sport, game, play, work, cushioning, safety "Red e" cleat